Business Wire

Saudi Arabia Unveils TOURISE: A Bold Global Platform Set to Redefine and Shape a New Horizon for Tourism at Scale

22.5.2025 16:00:00 EEST | Business Wire | Press release

Share

Saudi Arabia’s Minister of Tourism, His Excellency Ahmed Al-Khateeb officially launched TOURISE today, a bold new global platform designed to shape a new horizon and plot a shared roadmap for the next 50 years of tourism.

Built for ambition and backed by vision, TOURISE will convene a dynamic cross-section of public and private sector industry giants for the first time. Visionary leaders with tourism, technology, investment, sustainability, and cultural expertise will be connected to tackle critical challenges, unlock transformative opportunities and set the agenda for a sector that is sustainable, equitable and future-focused.

Along with global partners from multilateral institutions to private sector leaders, TOURISE is designed to unlock major, unprecedented deal flow, with high-value investment opportunities and access to breakthrough technologies set to be announced and activated through the platform.

TOURISE is no ordinary event; it is a global platform structured for year-round impact at scale through digital collaboration, thematic working groups, and cross-sector partnerships focused on long-term sector transformation. This will include authoring a series of white papers and global indices focused on tourism, sustainability and global economy, co-developed with leading international organizations, setting new benchmarks for the tourism sector.

The inaugural TOURISE Summit will take place in Riyadh from November 11 to 13, 2025. The program, which will also be livestreamed, will focus on four core themes: The Future of AI-Powered Tourism – Innovate or Fade; The Great Tourism Reset – Disruptive Business Models and Investment; Rebooting the Travel Experience – Upgrade in Progress; and Tourism that Works – for People, Planet, and Progress. A dedicated Innovation Zone will showcase breakthrough technologies and solutions from SMEs and mid to large corporations spanning AI, mobility, sustainability, and more from innovators across both public and private sectors.

According to the World Travel and Tourism Council (WTTC), this year tourism is on a strong upward trajectory, with the sector projected to contribute $11.7 trillion to the global economy - 10.3% of global GDP - highlighting a strong recovery. Yet, challenges such as shifting market dynamics, evolving traveler preferences, and capacity constraints continue to pose risks to maintain progress. At this critical juncture, TOURISE provides the strategic support needed to navigate these headwinds and sustain momentum.

Speaking at the virtual launch today, Minister of Tourism and TOURISE Chairman, His Excellency Ahmed Al-Khateeb said:Tourism is one of the most dynamic, connective forces in the world’s economy, supporting one in ten jobs globally. But as the world evolves, the sector must too. Whether adapting to technological disruption and changing traveler expectations, to addressing the urgent calls for sustainability and a more equitable approach to travel, TOURISE will be the much-needed platform to shape the future of tourism. It will unite the right people to develop innovative solutions and build partnerships, enabling the tourism sector to be more resilient, connected, and inclusive than ever before.”

Julia Simpson, World Travel & Tourism Council President & CEO, and TOURISE Advisory Board Member, who joined His Excellency to officially launch TOURISE, said: “We are delighted to be a part of this global initiative and continue our long-standing collaboration across the entire tourism ecosystem. For this industry to evolve and reach its full potential, public-private sector collaboration is critical to the continued success of Travel & Tourism worldwide. Together, we can address the challenges of today while co-creating a sustainable and innovative future for tomorrow.

TOURISE is backed by an advisory board chaired by His Excellency, with global experts from online travel agencies, tour operators, hoteliers, global tourism bodies, entertainment, and media, including: Mario Enzesberger, Founder and CEO, Liberty International Tourism Group; Mo Gawdat, Founder, One Billion Happy; Stephane Lefebvre, President, Cirque du Soleil Entertainment Group; Luis Maroto, CEO, Amadeus; and Julia Simpson CEO, World Travel & Tourism Council (WTTC); and Thomas Woldbye, CEO, Heathrow Airport.

The inaugural TOURISE Awards were also announced today - a stand-out recognition program celebrating destination excellence across the global tourism ecosystem. The awards will spotlight notable achievements in sustainability, digital transformation, inclusive tourism, cultural preservation, and workforce development. Nomination submissions will open on June 2, and award winners will be announced on the opening night of the TOURISE Summit.

TOURISE builds on Saudi Arabia’s growing role as a core contributor and driver in the global tourism landscape alongside major industry organizations including UN Tourism, WTTC, and the World Economic Forum (WEF). In 2024 alone, Saudi Arabia hit its Vision 2030 target of 100 million visitors annually, seven years early and the tourism sector contributed almost 5% to the national GDP, second only to oil production. This underscores Saudi Arabia’s rising influence and long-term commitment to supporting tourism as a driver of global progress and growth. In building TOURISE with global partners – from multilateral institutions to private sector leaders – Saudi Arabia will ensure its leadership will deliver worldwide impact.

To register your interest and become part of the platform shaping the next chapter of global tourism, visit www.tourise.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250522246016/en/

Contacts

For media inquiries, please contact: media@tourise.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

www.businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Galderma Receives U.S. FDA Approval for Differin ® Epiduo ® Acne Gel Prescription-to-OTC Switch22.5.2026 19:25:00 EEST | Press release

Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) use in ages 12 years and older, marking a significant Prescription-to-OTC transition in acne care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522074280/en/ The U.S. FDA approves Differin® Epiduo® Acne Gel Prescription-to-OTC switch This milestone represents yet another example of Galderma’s unique Integrated Dermatology strategy, demonstrating how proven innovations from its Therapeutic Dermatology portfolio can further strengthen its Dermatological Skincare offerings. The Prescription‑to‑OTC transition highlights Galderma’s scale and expertise in successfully commercializing dermatology innovations across the full spectrum of acne care. With the appro

Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 17:18:00 EEST | Press release

Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522186975/en/ Adam Plich, CEO and Co-Founder of Avanzanite Bioscience. “Thalassaemia is a complex, chronic and multisystem disease characterised by anaemia, ineffective erythropoiesis and haemo

ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 15:30:00 EEST | Press release

OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future

Enhertu ® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 15:00:00 EEST | Press release

Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority

Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 14:45:00 EEST | Press release

Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, signalling a shift in health systems from late-stage treatment to earlier intervention. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522587414/en/ Selected from 393 submissions across 68 countries, the winning teams were recognised through the inaugural ‘Future Health Challenge 2026: Building Anticipatory Health Systems through Population Sensing’, delivered by Future Health – A Global Initiative by Abu Dhabi in collaboration with MIT Solve. Health systems globally are facing rising costs and persistent delays in diagnosis, with many conditions still identified only after symptoms become severe. At the sam

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye